Vulnerability Description
A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to fetch arbitrary files from the server's web server.
CVSS Score
7.5
HIGH
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Supremainc | Biostar 2 | < 2.9.1 |
Related Weaknesses (CWE)
References
- https://claroty.com/team82/disclosure-dashboard/cve-2023-33365Third Party Advisory
- https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291Release NotesVendor Advisory
- https://claroty.com/team82/disclosure-dashboard/cve-2023-33365Third Party Advisory
- https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291Release NotesVendor Advisory
FAQ
What is CVE-2023-33365?
CVE-2023-33365 is a vulnerability with a CVSS score of 7.5 (HIGH). A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to fetch arbitrary files from the server's web server.
How severe is CVE-2023-33365?
CVE-2023-33365 has been rated HIGH with a CVSS base score of 7.5/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2023-33365?
Check the references section above for vendor advisories and patch information. Affected products include: Supremainc Biostar 2.